Physician

Molly Bridget Kitley, MD

According to 2025 Medicare claims, Molly Kitley, MD (NPI: 1720578131) practices dermatology in the Bloomington, IN market, with the plurality of this provider's patient population coming from Monroe, IN. This provider's primary affiliated billing organization is DERMATOLOGY CENTER OF SOUTHERN INDIANA, P.C. (NPI: 1659451755; TIN: 35-1333192) and primary practice location at 47403-4792.

Kitley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 495 traditional Medicare patients, billed 3,111 HCPCS/CPT codes, and received $104,708 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,036 prescription claims across 325 beneficiaries totaling $359,070 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 101 records totaling $1,827. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $166 to $359,070. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$52K$105K2022 Medicare payment: $11,092 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $84,622 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $104,708 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202268258$11,092
20234182,402$84,622
20244953,111$104,708

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$180K$359K2018 Drug cost: $166 (USD; Tot_Drug_Cst)2019 Drug cost: $338 (USD; Tot_Drug_Cst)2020 Drug cost: $641 (USD; Tot_Drug_Cst)2021 Drug cost: $36,974 (USD; Tot_Drug_Cst)2022 Drug cost: $15,908 (USD; Tot_Drug_Cst)2023 Drug cost: $210,800 (USD; Tot_Drug_Cst)2024 Drug cost: $359,070 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181316$166
20192033$338
20201119$641
20212151$36,974
20224572$15,908
2023224601$210,800
20243251,036$359,070

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths104118$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more322407$50
11102Biopsy of related skin growth, first growth136156$49
17000Destruction of precancer skin growth, 1 growth266314$30
17003Destruction of precancer skin growth, 2-14 growths2191,368$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab551,526$203,342
Humira(Cf) PenAdalimumab12336$80,548
KetoconazoleKetoconazole2547,748$5,369
Clobetasol PropionateClobetasol Propionate792,319$4,447
MetronidazoleMetronidazole421,302$2,734

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.101$1,827Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Molly Bridget Kitley, MD?

Tedicare shows public-source Medicare data for Molly Bridget Kitley, MD (NPI 1720578131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Molly Bridget Kitley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Molly Bridget Kitley, MD?

Molly Bridget Kitley, MD is linked to DERMATOLOGY CENTER OF SOUTHERN INDIANA, P.C. (billing NPI 1659451755) in the available physician profile data.

Does Molly Bridget Kitley, MD have Open Payments data?

Molly Bridget Kitley, MD has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.